Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
277
-
Total 13F shares, excl. options
-
35.8M
-
Shares change
-
+1.89M
-
Total reported value, excl. options
-
$2.45B
-
Value change
-
+$128M
-
Put/Call ratio
-
0.04
-
Number of buys
-
126
-
Number of sells
-
-139
-
Price
-
$68.44
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q4 2024
329 filings reported holding CNMD - CONMED Corp - Common Stock as of Q4 2024.
CONMED Corp - Common Stock (CNMD) has 277 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.8M shares
.
Largest 10 shareholders include BlackRock, Inc. (4.94M shares), VANGUARD GROUP INC (3.57M shares), EARNEST PARTNERS LLC (2.81M shares), Capital Research Global Investors (1.58M shares), STATE STREET CORP (1.36M shares), Champlain Investment Partners, LLC (1.3M shares), BANK OF AMERICA CORP /DE/ (1.25M shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (1M shares), SEI INVESTMENTS CO (930K shares), and MACQUARIE GROUP LTD (930K shares).
This table shows the top 277 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.